News
ReproNovo Announces First Participant Included in U.S. Phase 2 Trial of RPN-001 for Male Infertility
RPN-001 is a novel orally administered aromatase inhibitor being developed for the treatment of infertility in men with low serum testosteroneNo FDA-approved oral therapies currently exist for this ...
Fertility treatment advocates have expressed concerns about a new Arkansas law they say is meant to cast doubt on the ...
Morgantown, W.Va.-based WVU Medicine has doubled the size of its Center for Reproductive Medicine and opened new services to families. The center was established in 2002 and offers individualized ...
Genetics plays a crucial role in reproductive medicine, impacting both fertility and the health of offspring. According to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results